Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP001400

Drug Information
NameMepyramine maleate    
SynonymsMolPort-003-666-277; Pyranisamine maleate; N-(p-Methoxybenzyl)-N,N'-dimethyl-N-2-pyridyl-1,2-ethanediamine, maleic acid salt; Mepyramine maleate; Prefrin A; N-(dimethylaminoethyl)-N-(p-methoxyphenyl)-alpha-aminopyridine maleate; AH; N-(4-methoxybenzyl)-N',N'-dimethyl-N-pyridin-2-ylethane-1,2-diamine but-2-enedioate; Histan; EINECS 200-422-7; N-(4-Methoxyphenyl)methyl-N',N'-dimethyl-N-(2-pyridinyl)-1,2-ethanediamine maleate salt; 2-((2-(Dimethylamino)ethyl)(p-methoxybenzyl)amino)pyridine bimaleate; C16H21N3O.C4H4O4; Pyrilamine maleate salt; NSC 3604; NCGC00094209-05; Histavet-P; AB1004850; Renstamin; CHEMBL1201006; Mepyramine maleate salt; Thylogen maleate; Minihist; (Z)-but-2-enedioic acid; N'-[(4-methoxyphenyl)methyl]-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine; HMS1920N10; N-(p-me thoxybenzyl)-N',N'-dimethyl-N-(alpha-pyridyl)ethylenediamine maleate; SPECTRUM1500519; WLN: T6NJ BN1R DO1&2N1&1 &OV1U1VO; NCGC00094209-03; Pyranilamine maleate; CCRIS 1330; Enrumay; MLS000069668; Mepyramine maleate salt; N-(4-Methoxyphenyl)methyl-N inverted exclamation marka,N inverted exclamation marka-dimethyl-N-(2-pyridinyl)-1,2-ethanediamine maleate salt; Pymafed; Pyra-Maleate; 2-((2-(Dimethylamino)ethyl)(p-methoxybenzyl)amino)pyridine maleate; AC1NR4H4; MLS001148634; Pyramal maleate; Pyridine, 2-[[2-(dimethylamino)ethyl](p-methoxybenzyl)amino]-, maleate (1:1); P 5514; 2-[[2-(Dimethylamino)ethyl](p-methoxybenzyl)amino]pyridine maleate; Paramal; Pyraninyl; 1,2-Ethanediamine, N-[(4-methoxyphenyl)methyl]-N',N'-dimethyl-N-2-pyridinyl-, (Z)-2-butenedioate (1:1); N-p-Methoxybenzyl-N',N'-dimethyl-N-alpha-pyridylethylenediamine maleate; Pyra maleate; Kriptin maleate; Histavet-P (veterinary); Dorantamin maleate; N-Dimethylaminoethyl-N-p-methoxy-alpha-aminopyridine maleate; Anisopyradamine; SMR000058495; Anthisan maleate; N-(p-methoxybenzyl)-N',N'-dimethyl-N-(alpha-pyridyl)ethylenediamine maleate; Diaminide maleate; Antihist; NCGC00094209-01; Pyrilamine maleate [USAN]; HMS500I17; CID5284451; LS-251; Neoantergan maleate; Mepiramine maleate; NCGC00094209-04; Stangen maleate; component of Pyrdex; Statomin maleate; Midol Maximum Strength PMS; Neo-Antergan maleate; N,N-dimethyl-N'-{[4-(methyloxy)phenyl]methyl}-N'-pyridin-2-ylethane-1,2-diamine (2Z)-but-2-enedioate; Prestwick_634; N-(p-Methoxybenzyl)-N',N'-dimethyl-N-.alpha.-pyridylethylenediamine maleate; 5572-06-5; Pyrilamine maleate (USP); N,N-Dimethyl-N'-(4-methoxybenzyl)-N'-(2-pyridyl)ethylenediamine maleate; Histine; PYRILAMINE MALEATE; Mepyramine hydrogen maleinate; 2786 R.P. maleate; UNII-R35D29L3ZA; Paraminyl maleate; Pyridine, 2-((2-(dimethylamino)ethyl)(p-methoxybenzyl)amino)-, maleate (1:1); 1,2-Ethanediamine, N1-((4-methoxyphenyl)methyl)-N2,N2-dimethyl-N1-2-pyridinyl-, (2Z)-2-butenedioate (1:1); Histatex; D05660; SMR000653462; 2-((2-(dimethylamino)ethyl )(p-methoxybenzyl)amino)pyridine maleate; Pymafed (TN); 1,2-Ethanediamine, N-((4-methoxyphenyl)methyl)-N',N'-dimethyl-N-2-pyridinyl-, (2Z)-2-butenedioate (1:1); pyranilamine m aleate; PYRILAMINE MALEATE (SEE ALSO PYRILAMINE, CAS 91-84-9); 59-33-6; N-(Dimethylamino)ethyl-N-(p-methoxy)-.alpha.-aminopyridine maleate; component of Endotussin-NN; EU-0100890; NCGC00094209-02; P5514_SIGMA; 1,2-Ethanediamine, N-((4-methoxyphenyl)methyl)-N',N'-dimethyl-N-2-pyridinyl-, (Z)-2-butenedioate (1:1); Histosol; NSC3604; HMS1568J20; 2-[[2-(Dimethylamino)ethyl](p-methoxybenzyl)amino]pyridine bimaleate; HMS2092E11; Pyma; 2-((2-(Dimethylamino)ethyl)(p-methoxybenzyl)amino)pyridine maleate (1:1)    
IndicationAllergiesApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAnti-Asthmatic Agents    
CAS NumberCAS 59-33-6
FormularC21H27N3O5    
PubChem Compound IDCID 5284451.    
PubChem Substance IDSID 70057.    
TargetHistamine H1 receptorAntagonist[1][2][3]
Ref 1Antinociception induced by central administration of histamine in the formalin test in rats. Indian J Physiol Pharmacol. 2008 Jul-Sep;52(3):249-54. To Reference
Ref 2Receptor mediation and nociceptin inhibition of bradykinin-induced plasma extravasation in the knee joint of the rat. Inflamm Res. 2009 Jun 21. [Epub ahead of print] To Reference
Ref 3Design, synthesis and histamine H1-receptor antagonistic activity of some novel 4-amino-2-(substituted)-5-(substituted) aryl-6-[(substituted aryl) amino] pyrimidines. Arzneimittelforschung. 2009;59(5):243-7. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543